May 29, 2024 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the heart muscle. As it progresses, the heart can become unable to adequately …

Feb 19, 2025 · A big problem in ATTR-CM is the buildup of amyloid proteins in the heart. New treatments aim to remove these proteins, which could help your heart work better and ease symptoms.

Mar 2, 2022 · Transthyretin cardiac amyloidosis (or ATTR-CM for short) is a heart condition that can lead to heart failure, and it can be fatal. Unfortunately, many of its symptoms are vague, which may …

Transthyretin amyloidosis (ATTR-CM) is a buildup of faulty proteins (fibrils) on your heart or nerves. It can cause cardiomyopathy and heart failure.

Jun 26, 2025 · ATTR-CM (transthyretin amyloid cardiomyopathy) is a rare condition that causes a range of vague symptoms, including shortness of breath. If left untreated, it can progress to heart failure.

Nov 25, 2025 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is a condition that makes the heart stiff and less flexible, making it harder for the heart to pump. ATTR-CM doesn't always cause …

ATTR-CM (transthyretin amyloid cardiomyopathy) is a serious condition where protein deposits accumulate in heart tissues, including valves, leading to progressive heart failure. This rare but …

Apr 8, 2025 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of heart disease that happens when an abnormal protein called amyloid builds up in the heart. Because the symptoms can look …

Explore the red flags of transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM), the signs and symptoms that should prompt additional assessments.

ATTR-CM is a rare, serious, underrecognized, and underdiagnosed type of amyloidosis that affects your heart. It is a life-threatening progressive condition, which means it will get worse over time.